Boldenon Undecylenate GP

Understanding Boldenone Undecylenate GP

Boldenone Undecylenate GP is an esterified version of Boldenone, a derivative of testosterone with mild androgenic properties. The undecylenate ester extends the steroid’s release time, making it more convenient for users. It’s often referred to as Equipoise in bodybuilding communities due to its historical use in horse breeding.

Composition and Indication

Medical Action

• Promotes body tissue building processes in the presence of adequate protein and calories.
• Can reverse catabolism.
• Varying degrees of androgenic effects, suppressing endogenous testosterone release by inhibiting luteinizing hormone (LH).
• Stimulates erythropoiesis, causing nitrogen, sodium, potassium, and phosphorus retention while decreasing urinary calcium excretion.

Boldenone Undecylenate GP in Bodybuilding & Sports

Bodybuilders and athletes favor Boldenone Undecylenate GP for several reasons:

• Increased Muscle Growth and Strength: It promotes nitrogen retention, protein synthesis, and red blood cell production.
• Enhanced Endurance: Improved oxygenation due to increased red blood cells supports longer workouts.
• Improved Recovery: Reduced muscle damage repair time helps maintain progress during intense training cycles.
• Mild Androgenic Properties: Lower risk of typical androgenic side effects compared to other AAS.

Administration and Dosage

The optimal dose for bodybuilding purposes is typically between 200-600 mg per week, with some users reporting the optimum dose as 600 mg per week. Due to its long-acting ester, it can be administered every 2 days. However, always consult your doctor before starting any steroid cycle.

Potential Side Effects and Precautions

Boldenone Undecylenate GP is generally well-tolerated, but potential side effects include:

• Androgenic side effects: Acne, hair loss, aggression, and virilization in women.
• Hepatotoxicity: Liver damage with long-term use or excessive doses.
• Testicular atrophy and reduced sperm count: Due to suppression of endogenous testosterone production.

Boldenone is contraindicated in patients with hepatic dysfunction, hypercalcemia, cardiovascular disease, prostate carcinoma, breast cancer, and during pregnancy. Always consult your doctor before use.

Post-Cycle Therapy (PCT)

After finishing a Boldenone Undecylenate GP cycle, PCT is crucial to restore endogenous testosterone production. Common PCT protocols include Clomiphene Citrate or Tamoxifen Citrate for 4-6 weeks post-cycle.

References

• Boldenone undecylenate: a review of its pharmacological effects and clinical uses in dogs.
• Anabolic-Androgenic Steroids in Sports and Exercise: An Update.